Frost & Sullivan

AUGUST 29, 2024

However, the pharma/biopharma industry overall shows stagnant R&D activity. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%. As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8%

Biopharma 52

Biopharma Biotechnology Contract research organization Utilities 52

Frost & Sullivan

MARCH 22, 2024

However, the pharma/biopharma industry shows overall stagnant R&D activity. Small-to-mid and emerging biopharma players contribute over 16%. Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth.

Ecosystems 52

Ecosystems Biopharma Biotech Contract research organization 52

IBM Business Partners

MAY 6, 2024

The rise in the deployment of electronic patient-reported outcomes (ePROs), electronic clinical outcome assessments (eCOAs), and electronic informed consent (eConsent) from 2020 to 2021, primarily driven by contract research organizations underscores this shift.

Partnering capability and readiness 80

Partnering capability and readiness Biopharma Contract research organization Collaboration 80

Frost & Sullivan

APRIL 25, 2023

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. years, to become a truly global company with a diverse mix of public sector and biopharma clients.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

Jake Jorgovan

JUNE 3, 2024

Additionally, evaluating the firm's approach to communication and collaboration is crucial. BCG's expertise spans the entire biopharma value chain, focusing on digital, data, and next-generation capabilities. What drug development consulting firm will you choose?

Biopharma 130

Biopharma Biotech Biopharmaceuticals Life science 130

Jake Jorgovan

FEBRUARY 1, 2024

CSSi LifeSciences CSSi LifeSciences is a global, innovative Contract Research Organization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. Collaborative Approach: Choose a firm that values collaboration and open communication.

Life science 130

Life science Biotech Biotechnology Engineering 130

Jake Jorgovan

FEBRUARY 2, 2025

CSSi LifeSciences CSSi LifeSciences is a global, innovative Contract Research Organization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. Collaborative Approach: Choose a firm that values collaboration and open communication.

Life science 130

Life science Biotech Biotechnology Engineering 130